Testing and isolation to prevent overloaded health care facilities and to reduce death rates in the SARS-CoV-2 pandemic in Italy
Arnab Bandyopadhyay, Marta Schips, Tanmay Mitra, Sahamoddin Khailaie, Sebastian C. Binder, Michael Meyer-Hermann
doi: https://doi.org/10.1101/2020.10.12.20211169
Arnab Bandyopadhyay
1Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Marta Schips
1Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Tanmay Mitra
1Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Sahamoddin Khailaie
1Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Sebastian C. Binder
1Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Michael Meyer-Hermann
1Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
2Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, Braunschweig, Germany
3Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany

- supplementary[supplements/211169_file02.pdf]
Posted April 22, 2022.
Testing and isolation to prevent overloaded health care facilities and to reduce death rates in the SARS-CoV-2 pandemic in Italy
Arnab Bandyopadhyay, Marta Schips, Tanmay Mitra, Sahamoddin Khailaie, Sebastian C. Binder, Michael Meyer-Hermann
medRxiv 2020.10.12.20211169; doi: https://doi.org/10.1101/2020.10.12.20211169
Testing and isolation to prevent overloaded health care facilities and to reduce death rates in the SARS-CoV-2 pandemic in Italy
Arnab Bandyopadhyay, Marta Schips, Tanmay Mitra, Sahamoddin Khailaie, Sebastian C. Binder, Michael Meyer-Hermann
medRxiv 2020.10.12.20211169; doi: https://doi.org/10.1101/2020.10.12.20211169
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (728)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13076)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4895)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3089)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (193)